Photo by sharonmccutcheon from unsplash
The first-line treatment scenario of advanced non-small cell lung cancer (NSCLC) has been substantially revolutionized in the very last years, since immunotherapy has become a cornerstone. Click to show full abstract
The first-line treatment scenario of advanced non-small cell lung cancer (NSCLC) has been substantially revolutionized in the very last years, since immunotherapy has become a cornerstone.
Keywords:
anti angiogenesis;
immunotherapy patients;
chemo immunotherapy;
boosts chemo;
angiogenesis boosts;
patients egfr
Journal Title: Translational cancer research
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Translational cancer research
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!